2909 Laclede Ave
63103
St. Louis, MO
https://www.sigmaaldrich.com/US/en/home
Show place in map
Non-Members: $60
*Please note: Registration at the door is $60
*Online registration closes on March 10 at 3:00 PM CT.
Ticket includes GABO survey results presentation/panel discussion and appetizers/refreshments.
Join us at MilliporeSigma on March 11 for the live presentation and discussion of the results of the German American Business Outlook (GABO) survey, and learn what German companies in the US predict for the coming year.
What are the biggest challenges German subsidiaries in the US face in 2025? What’s going well?
The German American Business Outlook (GABO) is an annual survey of German-American business relations directed at German subsidiaries in the US assessing current economic developments and trends in transatlantic business.
Take the survey today - your voice counts!
With new administrations kicking off in 2025 in both the U.S. and Germany, the global business landscape faces new horizons. Share your perspectives on essential business topics, address your priorities, and let your view of the current economic situation be heard. Your voice counts!
The survey has 19 questions on business performance and outlook, workforce, sustainability, global and political topics, and your company's background.
Join us in St. Louis, Missouri at MilliporeSigma on March 11 for the live presentation and discussion of the results of the German American Business Outlook (GABO) survey, and learn what German companies in the US predict for the coming year.
Conducted by the German American Chambers of Commerce, this US-wide survey is one of the most important economic indicators of German American business relations.
Our panel of executives will discuss the results of the survey and what they mean for German subsidiaries in the Midwest.
Event Host Company - MilliporeSigma
At Merck KGaA around 63,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2023, Merck KGaA, Darmstadt, Germany, generated sales of € 21 billion in 65 countries.
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 27,000 employees and more than 55 total manufacturing and testing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services.
Stephanie Dal Porto
Coordinator, Events & Membership2025 GABO Missouri Panelists
David Nogales, MilliporeSigma, the Life Science business of Merck KGaA, Darmstadt, Germany
Head of Technology Strategy/St. Louis Hub Lead
Over 12 years with Merck KGaA, Darmstadt, Germany/MilliporeSigma in various roles of increasing responsibility. A Medical Doctor by training now at the intersection of Science and Technology David is driving the Technology Strategy for the R&D function of MilliporeSigma as part of the Life Science Technology Office globally. David also is leading the MilliporeSigma St. Louis Hub, the second biggest site of Life Science outside of the Darmstadt HQ.
About MilliporeSigma, the Life Science business of Merck KGaA, Darmstadt, Germany
Together with our colleagues, customers and stakeholders, we impact life and health with science. Before researchers can make scientific breakthroughs, they must have access to state-of-the-art tools, services and expertise to perform experiments and engineer new products. That’s where we come in.
We offer one of the broadest portfolios in the industry for scientists, best-in-class products for pharmaceutical development and manufacturing, and a fully integrated service organization to support CDMO and contract testing across traditional and novel modalities.
Our vision is a world where our innovative products, services and digital offerings help create solutions for people globally and a sustainable future for generations to come.
The life science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the US and Canada. Merck KGaA, Darmstadt, Germany is a global science and technology company with around 60,000 employees in more than 66 countries. Intended only for US/CA visitors.